Type of hormone therapy and risk of misclassification at mammography screening
Research output: Contribution to journal › Journal article
Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.
|Number of pages||7|
|Publication status||Published - 1 Feb 2011|
- Aged, Breast Neoplasms, Carcinoma, Denmark, Diagnostic Errors, Early Detection of Cancer, Female, Hormone Replacement Therapy, Humans, Mammography, Mass Screening, Middle Aged, Risk, Treatment Outcome